The startup develops a wearable biosensor that provides real-time monitoring of hemodynamic parameters for heart failure management. This technology enables patients to track vital signs and receive alerts for potential health issues, facilitating proactive communication with healthcare providers.
Funding
$2.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Heart failure patients often experience high rehospitalization rates and mortality, leading to significant healthcare costs. Effective management requires frequent monitoring of hemodynamic parameters, which is challenging to achieve outside of clinical settings. The lack of continuous, real-time data hinders proactive intervention and personalized treatment adjustments.
Solution
This startup offers a wearable biosensor coupled with a digital therapeutic platform for remote hemodynamic monitoring in heart failure patients. The device continuously tracks vital signs, providing real-time data and alerts for potential health issues. This enables patients to proactively manage their condition and communicate with healthcare providers, facilitating timely intervention and reducing the risk of rehospitalization. The platform aims to improve patient outcomes and reduce the economic burden associated with heart failure management.
Target Audience
The primary target audience includes heart failure patients, cardiologists, and healthcare providers involved in chronic disease management.
Features
- Continuous, non-invasive monitoring of key hemodynamic parameters
- Real-time alerts for deviations from personalized thresholds
- Secure data transmission to a cloud-based platform
- Patient-facing mobile application for self-management and communication
- Clinician dashboard for remote patient monitoring and data analysis
- Integration with existing electronic health record (EHR) systems